Cargando…
Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation
Drug targeting and nanomedicine are different strategies for improving the delivery of drugs to their target. Several antibodies, immuno-drug conjugates and nanomedicines are already approved and used in clinics, demonstrating the potential of such approaches, including the recent examples of the DN...
Autores principales: | Salvati, Anna, Poelstra, Klaas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777931/ https://www.ncbi.nlm.nih.gov/pubmed/35057111 http://dx.doi.org/10.3390/pharmaceutics14010217 |
Ejemplares similares
-
Ultrasound and Nanomedicine for Cancer-Targeted Drug Delivery: Screening, Cellular Mechanisms and Therapeutic Opportunities
por: Li, Chien-Hsiu, et al.
Publicado: (2022) -
Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect
por: Nehoff, Hayley, et al.
Publicado: (2014) -
Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue
por: Gote, Vrinda, et al.
Publicado: (2021) -
Heterocyclic Molecular Targeted Drugs and Nanomedicines for Cancer: Recent Advances and Challenges
por: Liu, Junxia, et al.
Publicado: (2023) -
Targeted Drug Delivery — From Magic Bullet to Nanomedicine: Principles, Challenges, and Future Perspectives
por: Tewabe, Ashagrachew, et al.
Publicado: (2021)